SB

Samsara BioCapital Portfolio holdings

AUM $489M
1-Year Est. Return 135.25%
This Quarter Est. Return
1 Year Est. Return
+135.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$570M
AUM Growth
+$85.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$47.2M
2
+$4.12M
3
+$1.62M

Top Sells

1
+$14.9M
2
+$9.35M
3
+$7.35M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$7.28M
5
CNTA
Centessa Pharmaceuticals
CNTA
+$6.52M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$198M 34.81%
5,161,888
2
$77.1M 13.52%
4,519,361
3
$47.2M 8.28%
+2,256,022
4
$34.7M 6.09%
4,598,828
5
$22M 3.86%
1,208,473
6
$19.4M 3.41%
613,921
-295,658
7
$15.9M 2.8%
967,527
-441,882
8
$12.6M 2.21%
1,458,875
-161,812
9
$12.1M 2.13%
308,151
-378,684
10
$11.4M 2.01%
55,605
+20,060
11
$10.3M 1.81%
599,274
-10,588
12
$9.42M 1.65%
202,773
13
$7.79M 1.37%
1,675,579
14
$7.35M 1.29%
347,500
-347,501
15
$7.22M 1.27%
696,171
16
$7.09M 1.24%
640,688
17
$6.89M 1.21%
470,304
18
$6.28M 1.1%
2,868,035
19
$5.82M 1.02%
651,050
20
$5.69M 1%
345,293
21
$4.85M 0.85%
80,963
22
$4.57M 0.8%
396,000
-99,000
23
$4.28M 0.75%
360,414
24
$3.76M 0.66%
432,000
-48,000
25
$3.09M 0.54%
801,629
1
2 3